The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Dechert LLP

ONE INTERNATIONAL PLACE, 40TH FLOOR, 100 OLIVER STREET, BOSTON, MA 02110-2605, USA
Tel:
Work +1 617 728 7100
Fax:
Fax +1 617 426 6567
Email:
Web:
www.dechert.com

Thomas J Friedmann

Tel:
Work +1 617 728 7120
Email:
Dechert LLP

Work Department

Corporate

Career

Thomas J. Friedmann, co-chair of Dechert’s Global Corporate Finance and Capital Markets Practice, represents domestic and foreign issuers and investment banks in public and private securities transactions. Mr. Friedmann also advises corporate clients on matters relating to securities law, corporate governance, and general corporate matters, including financial restructuring and securitization transactions.

Education

Harvard College, A.B., 1985, magna cum laude; University of Virginia Darden School of Business, MBA, 1991; University of Virginia, J.D., 1991


United States: Finance

Capital markets: debt

Within: Capital markets: debt

Acting primarily for issuers, Dechert LLP is noted as ‘a leader in advising business development companies’, and is also well known in the life sciences sector. Recent highlights included James Lebovitz, who splits his time between Philadelphia and New York, advising a business development company on a $500m senior notes offering. In a high-profile multi-jurisdictional deal, Philadelphia partners William Lawlor and Ian Hartman advised Crown Holdings on two private placements of notes worth €335m and €500m respectively, which were issued by its French subsidiary. The team also advised Crown on a $875m private placement of notes issued by US subsidiaries. Boston-based Thomas Friedmann and New-York based David Rosenthal co-chair the corporate finance and capital markets practice.

[back to top]

Capital markets: equity offerings

Within: Capital markets: equity offerings

Collaborative, involved, professional and prompt’, Dechert LLP attracts praise for ‘seeking to understand the client’s business to provide a value-add service. The group, which acts for corporate issuers and investment banks, is particularly prominent in advising business development companies and life sciences clients on equity deals. Among its recent highlights, Philadelphia-based private equity specialist Kenneth Young advised Corporate Capital Trust, a business development company, on its NYSE listing. New York-based group co-chair David Rosenthal (‘a trusted and valued advisor’) acted alongside Philadelphia’s Gregory Schernecke to advise Aquestive Therapeutics on its $67.5m IPO. Other key contacts include Boston-based department co-chair Thomas Friedmann, Philadelphia-based James Lebovitz and business development company specialist Harry Pangas, who recently joined in Washington DC from Eversheds Sutherland.

[back to top]

Capital markets: global offerings

Within: Capital markets: global offerings

Business-oriented, committed and knowledgeable’, according to one source, Dechert LLP’s capital markets practice ‘works closely with the client to provide an active and prominent voice in internal dialogues’. The group, which is well weighted between issuer and manager mandates, attracts particular praise as ‘a specialist advisor to business development companies’; it is also well versed in life sciences matters. In a significant cross-border highlight, Philadelphia-based partners William Lawlor and Ian Hartman advised Crown Holdings on two euro-denominated private placements of notes worth a combined €835m (issued by a French subsidiary of Crown) and a simultaneous $875m private placement of notes (issued by US subsidiaries of Crown) — the team was supported by lawyers in London, Paris and Luxembourg. Boston-based Thomas Friedmann, who advised PennantPark Floating Rate Capital on its $138.6m notes offering in Israel, and New York-based David Rosenthal, who ‘seeks to understand the client’s business’, jointly lead the department.

[back to top]

Capital markets: high-yield debt offerings

Within: Capital markets: high-yield debt offerings

Dechert LLP’s high-yield debt practice is mainly active on behalf of issuers, with its client roster dominated by life sciences companies and permanent capital vehicles. The practice group, commended by sources for its ‘collaborative and business-focused approach’, can also draw on its global network for support in multi-jurisdictional matters. In Philadelphia, Stephen Leitzell recently advised B&G Foods on a $400m senior notes offering. New York-based life sciences expert David Rosenthal and Boston-based Thomas Friedmann co-chair the department.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to